These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6404377)

  • 1. Intermediate acting insulin given at bedtime: effect on blood glucose concentrations before and after breakfast.
    Francis AJ; Home PD; Hanning I; Alberti KG; Tunbridge WM
    Br Med J (Clin Res Ed); 1983 Apr; 286(6372):1173-6. PubMed ID: 6404377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two twice-daily insulin regimens: ultralente/soluble and soluble/isophane.
    Ward GM; Simpson RW; Ward EA; Turner RC
    Diabetologia; 1981 Oct; 21(4):383-6. PubMed ID: 7026334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart.
    Ashwell SG; Gebbie J; Home PD
    Diabet Med; 2006 Aug; 23(8):879-86. PubMed ID: 16911626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of two different multiple injection regimens on blood glucose control and patient acceptance in type 1 diabetes.
    Wolffenbuttel BH; van Ouwerkerk BM; Veldhuyzen BF; Geelhoed-Duijvestijn PH; Jakobsen G; van Doorn LG
    Diabet Med; 1990; 7(8):695-9. PubMed ID: 2147630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of pre-breakfast insulin injection and postprandial metabolic control in diabetic children.
    Kinmonth AL; Baum JD
    Br Med J; 1980 Mar; 280(6214):604-6. PubMed ID: 6989436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twenty-four-hour metabolic profiles in diabetic children receiving insulin injections once or twice daily.
    Werther GA; Jenkins PA; Turner RC; Baum JD
    Br Med J; 1980 Aug; 281(6237):414-8. PubMed ID: 7000260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semilente-insulin at bedtime is superior to NPH-insulin for the suppression of the dawn-phenomenon in adolescents with type-I-diabetes.
    Holl RW; Teller WM; Heinze E
    Exp Clin Endocrinol Diabetes; 1996; 104(5):360-4. PubMed ID: 8957270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inpatient diabetes management: examining morning practice in an acute care setting.
    Cohen LS; Sedhom L; Salifu M; Friedman EA
    Diabetes Educ; 2007; 33(3):483-92. PubMed ID: 17570879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human ultralente insulin: a comparison with porcine lente insulin as a twice-daily insulin in insulin-dependent diabetic patients with fasting hyperglycaemia.
    Francis AJ; Hanning I; Alberti KG
    Diabetes Res; 1986 Jun; 3(5):263-8. PubMed ID: 3527523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of morning and bed-time ultralente administration when using multiple injections in adolescence.
    Smith CP; Dunger DB; Mitten S; Hewitt J; Spowart K; Grant DB; Savage MO
    Diabet Med; 1988; 5(4):352-5. PubMed ID: 2968885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humalog Mix25 improves 24-hour plasma glucose profiles compared with the human insulin mixture 30/70 in patients with type 2 diabetes mellitus.
    Herz M; Arora V; Campaigne BN; Scholtz HE; Potgieter MA; Mollentze W
    S Afr Med J; 2003 Mar; 93(3):219-23. PubMed ID: 12768948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limitations in usefulness of single dose intermediate acting insulin: a rapid response pattern in some type I diabetics.
    Levin P; Falko JM; O'Dorisio TM; Cataland S
    Am J Med Sci; 1983; 286(3):11-7. PubMed ID: 6356914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nocturnal glucose metabolism after bedtime injection of insulin glargine or neutral protamine hagedorn insulin in patients with type 2 diabetes.
    Linn T; Fischer B; Soydan N; Eckhard M; Ehl J; Kunz C; Bretzel RG
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3839-46. PubMed ID: 18611975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid intravenous sodium acetoacetate infusion in man. Metabolic and kinetic responses.
    Owen OE; Reichard GA; Markus H; Boden G; Mozzoli MA; Shuman CR
    J Clin Invest; 1973 Oct; 52(10):2606-16. PubMed ID: 4729054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of i.v. insulin in well-controlled non-insulin-dependent diabetics undergoing major surgery.
    Raucoules-Aimé M; Labib Y; Levraut J; Gastaud P; Dolisi C; Grimaud D
    Br J Anaesth; 1996 Feb; 76(2):198-202. PubMed ID: 8777097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An exploratory study of the effect of using high-mix biphasic insulin aspart in people with type 2 diabetes.
    Dashora U; Ashwell SG; Home PD
    Diabetes Obes Metab; 2009 Jul; 11(7):680-7. PubMed ID: 19527481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of site and timing of the morning insulin injection in type 1 diabetes.
    Witt MF; White NH; Santiago JV
    J Pediatr; 1983 Oct; 103(4):528-33. PubMed ID: 6352884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of insulin and acute diabetes on plasma FFA and ketone bodies in the fasting rat.
    Bieberdorf FA; Chernick SS; Scow RO
    J Clin Invest; 1970 Sep; 49(9):1685-93. PubMed ID: 5452413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nocturnal blood glucose profiles in patients with type 1 diabetes mellitus on multiple (> or = 4) daily insulin injection regimens.
    Vervoort G; Goldschmidt HM; van Doorn LG
    Diabet Med; 1996 Sep; 13(9):794-9. PubMed ID: 8891454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.